131 related articles for article (PubMed ID: 34821169)
41. Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge.
Li JJX; Tse GM
Pathology; 2020 Oct; 52(6):627-634. PubMed ID: 32771211
[TBL] [Abstract][Full Text] [Related]
42. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast.
Sapino A; Bosco M; Cassoni P; Castellano I; Arisio R; Cserni G; Dei Tos AP; Fortunati N; Catalano MG; Bussolati G
Mod Pathol; 2006 Apr; 19(4):599-606. PubMed ID: 16554735
[TBL] [Abstract][Full Text] [Related]
43. Utility of Ki-67, CD10, CD34, p53, CD117, and mast cell content in the differential diagnosis of cellular fibroadenomas and in the classification of phyllodes tumors of the breast.
Vilela MH; de Almeida FM; de Paula GM; Ribeiro NB; Cirqueira MB; Silva AL; Moreira MA
Int J Surg Pathol; 2014 Sep; 22(6):485-91. PubMed ID: 24492332
[TBL] [Abstract][Full Text] [Related]
44. Survey of recurrent diagnostic challenges in breast phyllodes tumours.
Tan BY; Fox SB; Lakhani SR; Tan PH
Histopathology; 2023 Jan; 82(1):95-105. PubMed ID: 36468287
[TBL] [Abstract][Full Text] [Related]
45. β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.
Lacroix-Triki M; Geyer FC; Lambros MB; Savage K; Ellis IO; Lee AH; Reis-Filho JS
Mod Pathol; 2010 Nov; 23(11):1438-48. PubMed ID: 20693983
[TBL] [Abstract][Full Text] [Related]
46. Periductal stromal tumor of the breast in a young lady: A case report.
Arab W; Moubarak M; Fattah S; Khazen J; Khaddage A; El Kassis N; Atallah D
Breast J; 2021 Apr; 27(4):380-383. PubMed ID: 33474791
[TBL] [Abstract][Full Text] [Related]
47. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.
Livasy CA; Karaca G; Nanda R; Tretiakova MS; Olopade OI; Moore DT; Perou CM
Mod Pathol; 2006 Feb; 19(2):264-71. PubMed ID: 16341146
[TBL] [Abstract][Full Text] [Related]
48. Phyllodes tumor of the breast: a retrospective study of the impact of histopathological factors in local recurrence and distant metastasis.
Sawalhi S; Al-Shatti M
Ann Saudi Med; 2013; 33(2):162-8. PubMed ID: 23563006
[TBL] [Abstract][Full Text] [Related]
49. Low-grade fibromyxoid sarcoma of the breast: genetic characterization and immunohistochemical comparison to morphologic mimics.
Cloutier JM; Moreland A; Wang L; Kunder CA; Allard G; Wang A; Krings G; Charville GW; Bean GR
Hum Pathol; 2023 Sep; 139():17-26. PubMed ID: 37392946
[TBL] [Abstract][Full Text] [Related]
50. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
Silverman JS; Tamsen A
Histopathology; 1996 Nov; 29(5):411-9. PubMed ID: 8951485
[TBL] [Abstract][Full Text] [Related]
51. Associations of epithelial c-kit expression in phyllodes tumours of the breast.
Tawasil J; Go EM; Tsang JY; Ni YB; Ko CW; Tse GM
J Clin Pathol; 2015 Oct; 68(10):808-11. PubMed ID: 26056158
[TBL] [Abstract][Full Text] [Related]
52. Recurrent challenges in the evaluation of fibroepithelial lesions.
Giri D
Arch Pathol Lab Med; 2009 May; 133(5):713-21. PubMed ID: 19415945
[TBL] [Abstract][Full Text] [Related]
53. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.
Chen WH; Cheng SP; Tzen CY; Yang TL; Jeng KS; Liu CL; Liu TP
J Surg Oncol; 2005 Sep; 91(3):185-94. PubMed ID: 16118768
[TBL] [Abstract][Full Text] [Related]
54. Malignant phyllodes tumor of the breast: a systematic review.
Lissidini G; Mulè A; Santoro A; Papa G; Nicosia L; Cassano E; Ashoor AA; Veronesi P; Pantanowitz L; Hornick JL; Rossi ED
Pathologica; 2022 Apr; 114(2):111-120. PubMed ID: 35414723
[TBL] [Abstract][Full Text] [Related]
55. Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade.
Makretsov NA; Hayes M; Carter BA; Dabiri S; Gilks CB; Huntsman DG
Mod Pathol; 2007 Jan; 20(1):84-9. PubMed ID: 17143263
[TBL] [Abstract][Full Text] [Related]
56. [Clinicopathologic and molecular characterizations of Sertoli cell tumor, not otherwise specified of the testis].
Zhao M; Zhao DH; He HY; Zhang X; Ru GQ; He XL; Wang Z; Teng XD
Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):505-510. PubMed ID: 29996314
[No Abstract] [Full Text] [Related]
57. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast.
Barrio AV; Clark BD; Goldberg JI; Hoque LW; Bernik SF; Flynn LW; Susnik B; Giri D; Polo K; Patil S; Van Zee KJ
Ann Surg Oncol; 2007 Oct; 14(10):2961-70. PubMed ID: 17562113
[TBL] [Abstract][Full Text] [Related]
58. Fibroepithelial lesions of the breast with pleomorphic stromal giant cells: a clinicopathologic study of 4 cases and review of the literature.
Huo L; Gilcrease MZ
Ann Diagn Pathol; 2009 Aug; 13(4):226-32. PubMed ID: 19608080
[TBL] [Abstract][Full Text] [Related]
59. Ki67 and P53 Expression in Relation to Clinicopathological Features in Phyllodes Tumour of the Breast.
Mohd Ali NA; Nasaruddin AF; Mohamed SS; Wan Rahman WF
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2653-2659. PubMed ID: 32986365
[TBL] [Abstract][Full Text] [Related]
60. Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome.
Reith JD; Goldblum JR; Lyles RH; Weiss SW
Mod Pathol; 2000 May; 13(5):577-85. PubMed ID: 10824931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]